Begin main content

CDR Update 117

Last Updated: February 25, 2016
Result type: Reports
Product Line: CDR Update Newsletter
Issue: 117

CADTH Consultation: Proposed Revision to the CADTH Common Drug Review Procedure

CADTH is inviting stakeholder comments and feedback on the following proposed revision to the Procedure for the CADTH Common Drug Review:

Please access the consultation document as hyperlinked above.

Deadline for Feedback

Please email your feedback by 5:00 p.m. EST March 24, 2016, to feedback@cadth.ca. All feedback submitted as follows will be considered by CADTH.

How to Submit Your Feedback

  • To provide feedback, you must identify yourself — feedback provided by individuals who do not identify themselves and the organization they represent will not be considered.
  • Only one response per organization will be considered. If more than one response is received, only the first response received will be considered.
  • Feedback must be provided using 11-point font and saved in one of the following formats:
  • Microsoft Word document (.doc or .docx)
  • Unlocked PDF document that permits copying and pasting of text.
  • Feedback should be presented clearly and succinctly.
  • The maximum length of feedback is one page per response to this consultation.

Next Steps

The final decision regarding the proposed revision to the CADTH Common Drug Review (CDR) procedure will be made after careful assessment of stakeholder feedback generated from this consultation and communicated in a future CDR Update.

If you have any questions about the feedback process, please email us at feedback@cadth.ca. We thank you in advance for your interest.